UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000052210
Receipt number R000059582
Scientific Title Assessment of hazardous substances in surgical smoke exposed to staff in the operating room
Date of disclosure of the study information 2023/09/15
Last modified on 2024/03/13 11:46:03

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Assessment of hazardous substances in surgical smoke exposed to staff in the operating room

Acronym

Assessment of hazardous substances in surgical smoke exposed to staff in the operating room

Scientific Title

Assessment of hazardous substances in surgical smoke exposed to staff in the operating room

Scientific Title:Acronym

Assessment of hazardous substances in surgical smoke exposed to staff in the operating room

Region

Japan


Condition

Condition

Hepatobiliary and pancreatic surgical diseases requiring open laparotomy

Classification by specialty

Surgery in general Hepato-biliary-pancreatic surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

It is known that surgical smoke generated during the use of energy devices during surgery compaunds toxic substances. We are going to verify whether the exposure of operating room staff both inside and outside the surgical field to surgical smoke is higher than the norm or not.

Basic objectives2

Others

Basic objectives -Others

Safety of operating room staff

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Volatile organic compounds in surgery smoke will be measured and compared to the exposure levels of staff in the operating room and the Ministry of Health, Labor and Welfare/WHO reference values.

Key secondary outcomes

Volatile organic compounds in surgery-related smoke will be measured and exposure levels among staff in the operating room will be compared.


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Other

Interventions/Control_1

Two badge-type measuring devices are attached to the chest of the primary surgeon, anesthesiologist, direct care nurse, and indirect care nurse. After 5 minutes, the instruments are removed and the collection is completed.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients 20 years of age or older undergoing open surgery at the Department of Hepatobiliary and Pancreatic Surgery, The University of Tokyo Hospital. Patients who have given their own consent to this study.

Key exclusion criteria

Patients under 19 years of age. Patients who did not give consent for this study.

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Kiyoshi
Middle name
Last name Hasegawa

Organization

The University of Tokyo Hospital

Division name

Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery

Zip code

113-8655

Address

7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan

TEL

03-3815-5411

Email

hasegawa-2su@h.u-tokyo.ac.jp


Public contact

Name of contact person

1st name Yui
Middle name
Last name Sawa

Organization

The University of Tokyo Hospital

Division name

Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery

Zip code

113-8655

Address

7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan

TEL

03-3815-5411

Homepage URL


Email

ysawa-tky@umin.ac.jp


Sponsor or person

Institute

The University of Tokyo

Institute

Department

Personal name

Hasegawa Kiyoshi


Funding Source

Organization

SAKAI Clean, Health and Safety Foundation

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

The University of Tokyo

Address

7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan

Tel

03-5841-3600

Email

hy-ohrs@m.u-tokyo.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 09 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2023 Year 08 Month 22 Day

Date of IRB

2023 Year 09 Month 14 Day

Anticipated trial start date

2023 Year 09 Month 15 Day

Last follow-up date

2025 Year 09 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2023 Year 09 Month 14 Day

Last modified on

2024 Year 03 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000059582